Home600812 • SHA
North China Pharmaceutical Co Ltd
¥4.91
Apr 26, 3:59:55 PM GMT+8 · CNY · SHA · Disclaimer
Stock
Previous close
¥4.73
Day range
¥4.70 - ¥4.91
Year range
¥3.83 - ¥6.66
Avg Volume
9.91M
P/E ratio
1,722.81
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY)Dec 2023Y/Y change
Revenue
2.15B-18.32%
Operating expense
575.35M-22.72%
Net income
-23.08M96.83%
Net profit margin
-1.0896.10%
Earnings per share
EBITDA
291.06M7.89%
Effective tax rate
103.16%
Total assets
Total liabilities
(CNY)Dec 2023Y/Y change
Cash and short-term investments
988.28M-41.27%
Total assets
20.96B-1.25%
Total liabilities
14.69B-2.04%
Total equity
6.27B
Shares outstanding
1.72B
Price to book
1.53
Return on assets
1.26%
Return on capital
1.53%
Net change in cash
(CNY)Dec 2023Y/Y change
Net income
-23.08M96.83%
Cash from operations
430.54M-8.66%
Cash from investing
-452.90M-191.21%
Cash from financing
-398.91M65.80%
Net change in cash
-418.38M51.00%
Free cash flow
873.18M-11.91%
About
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Founded
Dec 20, 1992
Employees
10,159
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu